Add BrightSurf on Google Email

The Lancet


The Lancet Infectious Diseases: Non-hospitalised COVID-19 patients have low-risk of serious long-term effects, but report more visits to general practitioner following infection

A new study found that non-hospitalised SARS-CoV-2 infected individuals have a low risk of severe delayed effects, but still reported increased visits to general practitioners and outpatient clinics. The research highlights the need for clinicians to manage potential long-term conditions.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateMay 10, 2021

The Lancet Rheumatology: Largest study to date confirms non-steroidal anti-inflammatory medications do not result in worse COVID-19 outcomes

A new observational study published in The Lancet Rheumatology found that non-steroidal anti-inflammatory drugs (NSAIDs) taken prior to hospital admission for COVID-19 do not increase mortality rates. In fact, the use of NSAIDs was similar among patients who had taken them and those who had not. This large-scale study provides reassura...

SourceThe Lancet·JournalThe Lancet Rheumatology·DateMay 7, 2021

The Lancet Psychiatry: Largest study to date suggests link between COVID-19 infection and subsequent mental health and neurological conditions

A large study found that COVID-19 survivors are at a higher risk of developing anxiety, mood disorders, stroke, dementia, and other neurological conditions. The study analyzed data from over 236,000 patients and estimated that one in three COVID-19 survivors developed a neurological or psychiatric condition within six months.

SourceThe Lancet·JournalThe Lancet Psychiatry·DateApr 6, 2021

The Lancet: Seroprevalence study from Wuhan suggests 6.9% of population had COVID-19 antibodies by April 2020 -- including 40% with neutralizing antibodies that lasted for at least 9 months -- but 82% of cases were asymptomatic

A seroprevalence study of 9,542 residents in Wuhan found that 6.9% had COVID-19 antibodies, including 82% with asymptomatic infections. Neutralizing antibodies developed by 40%, remaining stable for at least 9 months.

SourceThe Lancet·JournalThe Lancet·DateMar 18, 2021

The Lancet Healthy Longevity: Study finds racial and ethnic disparities in flu vaccine uptake among people aged 65 and older in the USA

A new study published in The Lancet Healthy Longevity found significant racial and ethnic disparities in the uptake of seasonal flu vaccines among people aged 65 and over in the USA. Among those who received a vaccine, minorities were 26-32% less likely to receive the High Dose Vaccine, which is more effective in older adults.

SourceThe Lancet·JournalThe Lancet Healthy Longevity·DateFeb 18, 2021

The Lancet: COVID-19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, and successful rollout

To ensure an effective global immunization strategy against COVID-19, vaccines must be produced at scale, priced affordably, and allocated globally. The authors assess the potential contribution of leading vaccines using a traffic light system, highlighting production challenges and the need for equitable distribution. Governments and ...

SourceThe Lancet·JournalThe Lancet·DateFeb 12, 2021

The Lancet Planetary Health: Millions of lives saved annually by 2040 if countries raise their climate ambitions to meet Paris Agreement targets, modelling study suggests

A new study published in The Lancet Planetary Health highlights the benefits to health if countries adopt climate plans consistent with the Paris Agreement. Adopting such policies could save up to 6.4 million lives due to better diet, cleaner air, and increased exercise per year across nine countries.

SourceThe Lancet·JournalThe Lancet Planetary Health·DateFeb 9, 2021

The Lancet Child & Adolescent Health: SARS-CoV-2 seroprevalence study in daycare centres in France suggests low rates of infection in very young children

A study published in The Lancet Child & Adolescent Health found low SARS-CoV-2 seroprevalence rates among French daycare children, indicating minimal transmission within daycare centers. The rate of infection was approximately 3.7%, with positive cases likely infected by an adult household member.

SourceThe Lancet·JournalThe Lancet Child & Adolescent Health·DateFeb 8, 2021

The Lancet Public Health: Weekly testing and two-week isolation most cost-effective strategy to control spread of COVID-19 in high transmission areas, US study suggests

A US study published in The Lancet Public Health journal suggests that weekly COVID-19 testing with a two-week isolation period is the most cost-effective strategy to mitigate the spread of the virus in high-transmission areas. Monthly testing and one-week isolation are more cost-effective when transmission rates are low to moderate.

SourceThe Lancet·JournalThe Lancet Public Health·DateFeb 4, 2021

The Lancet Child & Adolescent Health: 40% of countries show no progress in reducing cigarette smoking in adolescents over last 20 years

A study of over 1.1 million adolescents from 140 countries found that cigarette smoking decreased in 80 countries but remained unchanged or increased in 60 countries between 1999 and 2018. Other tobacco products like chewing tobacco and e-cigarettes also showed increased use in many countries.

SourceThe Lancet·JournalThe Lancet Child & Adolescent Health·DateFeb 2, 2021

The Lancet Public Health: Ethnic health disparities among older adults in England equivalent to 20-year age difference, even before COVID-19

A new study finds that ethnic health disparities among older adults in England are significant, with certain groups experiencing worse quality of life than White British people. The study highlights the need for policy reform and long-term research to address structural and institutional racism.

SourceThe Lancet·JournalThe Lancet Public Health·DateJan 28, 2021

The Lancet: Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries

A new study estimates that vaccination against 10 major pathogens will have prevented 69 million deaths in low-income and middle-income countries between 2000 and 2030. Vaccination programs are expected to reduce mortality from these diseases by 72% for those born in 2019, with the greatest impact on children under five.

SourceThe Lancet·JournalThe Lancet·DateJan 28, 2021

The Lancet Public Health: Modelling study estimates impact of 'test to release' strategy to reduce - or replace - quarantine for contacts of COVID-19 cases

A UK modelling study suggests that completing the WHO-recommended 14-day quarantine period after COVID-19 exposure can prevent 59% of SARS-CoV-2 transmission. Testing people on the seventh day of quarantine with a PCR or lateral flow antigen test may reduce quarantine time to 7 days without raising transmission risk.

SourceThe Lancet·JournalThe Lancet Public Health·DateJan 20, 2021

The Lancet Planetary Health: Meeting India's air quality targets across south Asia may prevent 7% of pregnancy losses, modelling study estimates

A modelling study suggests that pregnant women in India, Pakistan, Bangladesh, exposed to poor air quality, are at higher risk of stillbirths and miscarriages. The study estimated 349,681 pregnancy losses per year associated with exposure to PM2.5 concentrations exceeding India's air quality standard.

SourceThe Lancet·JournalThe Lancet Planetary Health·DateJan 6, 2021

The Lancet Respiratory Medicine: COVID-19 causes more severe disease than seasonal influenza, comparison of data from over 130,000 hospitalised patients confirms

A comparison of data from over 130,000 hospitalised patients found that COVID-19 is associated with a higher death rate and severity of illness compared to seasonal influenza. The study also revealed that COVID-19 patients were more likely to require invasive mechanical ventilation and intensive care.

SourceThe Lancet·JournalThe Lancet Respiratory Medicine·DateDec 17, 2020

The Lancet Global Health: Pregnant women excluded from three-quarters of COVID-19 treatment trials

A review of international trial registry data reveals that pregnant women are routinely excluded from most clinical treatment trials for COVID-19, despite being at increased risk of severe illness. The authors argue that this exclusion poses a significant risk to the potential effectiveness and safety of treatments for pregnant women.

SourceThe Lancet·JournalThe Lancet Global Health·DateDec 16, 2020

The Lancet Infectious Diseases: Largest seroprevalence study in the region finds number of people infected with SARS-CoV-2 in Iran may be higher than expected

A large-scale seroprevalence study in Iran found that around 17.1% of the population has been infected with SARS-CoV-2, with significant variations between cities and occupations. Despite this high rate, a substantial proportion of the population remains susceptible to infection.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateDec 15, 2020

The Lancet Child & Adolescent Health: Black children diagnosed with severe sepsis are more likely to die than White or Hispanic children, hospital data suggests

A recent study published in The Lancet Child & Adolescent Health found that Black children diagnosed with severe sepsis have a 20% greater odds of death compared to their White and Hispanic peers. Additionally, 'other' insurance status was associated with increased mortality, and Black and Hispanic children had longer hospital stays.

SourceThe Lancet·JournalThe Lancet Child & Adolescent Health·DateDec 14, 2020

The Lancet Infectious Diseases: Confirmed COVID-19 cases and outbreaks were low in schools and nurseries in England that re-opened after the first lockdown

Research found COVID-19 cases and outbreaks were extremely low in schools and nurseries in England during the summer of 2020. Outbreaks correlated strongly with local infection rates, highlighting the importance of controlling community transmission to protect educational settings.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateDec 8, 2020

The Lancet Public Health: Travel restrictions must be used in a targeted way to be effective at controlling local COVID-19 transmission, modelling study suggests

A modelling study published in The Lancet Public Health found that targeted travel restrictions are effective in controlling local COVID-19 transmission in countries with low numbers of cases or strong travel links to infected countries. Travel restrictions are unlikely to be effective when the virus is spreading rapidly within a country.

SourceThe Lancet·JournalThe Lancet Public Health·DateDec 7, 2020